Panagora Asset Management’s Histogen Inc. Common Stock HSTO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-24
Closed -$1K 2696
2019
Q2
$1K Buy
+24
New +$4.17K ﹤0.01% 2584
2018
Q3
Sell
-125
Closed -$107K 2490
2018
Q2
$107K Sell
125
-542
-81% -$450K ﹤0.01% 1828
2018
Q1
$783K Sell
667
-98
-13% -$108K ﹤0.01% 1247
2017
Q4
$707K Buy
765
+213
+39% +$197K ﹤0.01% 1260
2017
Q3
$607K Sell
552
-135
-20% -$154K ﹤0.01% 1287
2017
Q2
$791K Buy
+687
New +$836K ﹤0.01% 1213

Other funds holding HSTO

Panagora Asset Management's HSTO Position: Q3 2019 in Review

Panagora Asset Management sold out of Histogen Inc. Common Stock (HSTO) in Q3 2019, closing a stake of 24 shares — an estimated $1K sold.

Panagora Asset Management first reported a position in HSTO in Q2 2017 and held it in 6 quarters. The position peaked at $791K in Q2 2017. 29 funds tracked by Wall St. Rank hold HSTO as of Q3 2019.

  • Panagora Asset Management reported no remaining Histogen Inc. Common Stock position as of Q3 2019 after selling out during the quarter.
  • Panagora Asset Management sold 24 Histogen Inc. Common Stock shares in Q3 2019, an estimated $1K.
  • Panagora Asset Management first reported a position in Histogen Inc. Common Stock in Q2 2017 and held it in 6 quarters.
  • Panagora Asset Management's Histogen Inc. Common Stock position peaked at $791K in Q2 2017.
  • 29 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2019.

Based on Panagora Asset Management's 13F filing for Q3 2019, filed 12 Nov 2019.